Skip to main content

Table 1 The chi-square test of the relation between risk score and clinical features in TCGA cohort

From: Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma

Clinical features TCGA, n = 365
High risk Low risk P
Survival status    < 0.001
 Survived 45 194  
 Died 51 75  
 Age    0.89
 ≥ 60 years 52 148  
 < 60 years 44 121  
Sex    0.23
 Male 60 186  
 Female 36 83  
Histological grade    0.06
 G1–2 53 177  
 G3–4 42 88  
 Gx 1 4  
Stage    < 0.001
 I–II 55 199  
 III–IV 35 52  
x 6 18  
T classification    < 0.01
 T1–2 61 210  
 T3–4 35 56  
 Tx 0 3  
N classification    0.30
 N0 66 182  
 N1 2 2  
 Nx 28 85  
M classification    0.12
 M0 69 194  
 M1 2 1  
 Mx 25 74  
Cirrhosis status    0.74
 No cirrhosis 16 61  
 Cirrhosis 30 102  
 Unknown 50 106  
Recurrence status    0.38
 No recurrence 35 117  
 Recurrence 43 114  
 Unknown 18 38  
Hepatitis status    0.81
 Hepatitis B 21 67  
 Hepatitis C 11 32  
 No hepatitis 64 170  
  1. The cases with “Gx,” “Tx,” “Nx,” “Mx,” stage “x,” cirrhosis status “unknown,” and recurrence status “unknown” were excluded from the chi-square test